Passage Bio, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Passage Bio, Inc. now
Current reporting with the operating signal separated from the noise.
Passage Bio, Inc. (PASG) Is Up 24.26% in One Week: What You Should Know
The story matters when it changes Passage Bio, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Passage Bio, Inc. (NASDAQ:PASG) Q4 2022 Earnings Call Transcript
Investors are testing whether Passage Bio, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.What Kind Of Investors Own Most Of Passage Bio, Inc. (NASDAQ:PASG)?
The story matters when it changes Passage Bio, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest PASG filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Passage Bio, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →